НовостиBenzingaHC Wainwright & Co. Maintains Buy on Palvella Therapeutics, Lowers Price Target to $246 HC Wainwright & Co. Maintains Buy on Palvella Therapeutics, Lowers Price Target to $246 Benzinga 2026.10.12 11:31 (GMT+0) Открыть на Benzinga Другие новости